Published in Gastroenterology on October 01, 2001
Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery | NCT04031716
Opportunities for the replacement of animals in the study of nausea and vomiting. Br J Pharmacol (2009) 2.39
Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev (2011) 1.75
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology (Berl) (2003) 1.50
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew). Psychopharmacology (Berl) (2004) 1.43
Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve. J Physiol (2004) 1.29
Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol (2012) 1.11
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. Br J Pharmacol (2008) 1.11
Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol (2011) 1.10
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat. Psychopharmacology (Berl) (2007) 1.08
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol (2013) 1.08
Endocannabinoids and the gastrointestinal tract: what are the key questions? Br J Pharmacol (2007) 1.07
Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Psychopharmacology (Berl) (2003) 1.06
Endocannabinoid overactivity and intestinal inflammation. Gut (2006) 1.06
Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. J Physiol (2003) 1.03
Motion sickness, stress and the endocannabinoid system. PLoS One (2010) 1.02
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype. Am J Physiol Gastrointest Liver Physiol (2010) 0.99
Involvement of cannabinoid receptors in gut motility and visceral perception. Br J Pharmacol (2004) 0.99
Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats. Br J Pharmacol (2010) 0.99
The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew). Physiol Behav (2009) 0.97
Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol (2004) 0.96
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. Psychopharmacology (Berl) (2006) 0.93
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS). Exp Brain Res (2014) 0.89
AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion. Br J Pharmacol (2006) 0.89
Cannabinoid hyperemesis syndrome. Hosp Pharm (2013) 0.89
Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats. Br J Pharmacol (2012) 0.89
Food restriction, refeeding, and gastric fill fail to affect emesis in musk shrews. Am J Physiol Gastrointest Liver Physiol (2009) 0.89
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Psychopharmacology (Berl) (2011) 0.88
Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density. Physiol Behav (2011) 0.88
Analysis of endocannabinoids, their congeners and COX-2 metabolites. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.87
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. Can J Gastroenterol (2011) 0.85
Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans. Br J Pharmacol (2008) 0.85
Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew. Eur J Pharmacol (2007) 0.82
The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex. Br J Pharmacol (2012) 0.81
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice. PLoS One (2015) 0.81
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. Br J Pharmacol (2013) 0.81
Cannabis and endocannabinoid modulators: Therapeutic promises and challenges. Clin Neurosci Res (2005) 0.80
Cannabinoids facilitate the swallowing reflex elicited by the superior laryngeal nerve stimulation in rats. PLoS One (2012) 0.80
Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus. Psychopharmacology (Berl) (2014) 0.79
Simultaneous Quantification of Anandamide and Other Endocannabinoids in Dorsal Vagal Complex of Rat Brainstem by LC-MS. Chromatographia (2009) 0.79
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting. Pharmaceuticals (Basel) (2010) 0.79
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats. J Negat Results Biomed (2016) 0.78
Anticipatory nausea in animal models: a review of potential novel therapeutic treatments. Exp Brain Res (2014) 0.78
The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. Neurogastroenterol Motil (2016) 0.77
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus). Br J Pharmacol (2013) 0.77
Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration. Neurosci Lett (2010) 0.76
Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review. J Adv Res (2013) 0.76
Emesis, appetite, and endocannabinoids. Gastroenterology (2002) 0.76
Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses. Methods Enzymol (2010) 0.76
Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting. Front Pharmacol (2016) 0.75
A unique therapeutic approach to emesis and itch with a proanthocyanidin-rich genonutrient. J Transl Med (2008) 0.75
Nausea and Vomiting. Curr Treat Options Gastroenterol (2002) 0.75
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev (2002) 8.50
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci (1999) 4.65
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience (1998) 4.39
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature (1996) 3.79
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis (2000) 3.63
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med (2001) 3.17
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol (1995) 2.95
Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology (1998) 2.46
Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene (2006) 2.33
Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest (1996) 2.31
Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci (2001) 2.15
Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current. J Neurosci (2000) 2.15
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol (1999) 2.12
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci U S A (1993) 2.10
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol (1997) 2.05
Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg (2004) 1.89
Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol (1999) 1.83
Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem (1999) 1.82
Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J Neurosci (1999) 1.80
Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J (1997) 1.80
Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience (1999) 1.77
Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett (1998) 1.64
Visualization and spectroscopy of a metal-molecule-metal bridge. Science (2003) 1.63
Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J Neurosci (2001) 1.63
Modulation of single vagal efferent fibre discharge by gastrointestinal afferents in the rat. J Physiol (1978) 1.60
Failed coronary stent deployment. Am Heart J (1998) 1.60
Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J Neurosci (2001) 1.58
Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon. Neurogastroenterol Motil (2005) 1.51
Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry (2008) 1.46
Genetic interactions between CDC31 and KAR1, two genes required for duplication of the microtubule organizing center in Saccharomyces cerevisiae. Genetics (1994) 1.42
The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J Biol Chem (2000) 1.40
Vibrationally resolved fluorescence excited with submolecular precision. Science (2003) 1.38
Role of guanylate cyclase-cGMP systems in halothane-induced vasodilation in canine cerebral arteries. Anesthesiology (1992) 1.38
Towards early defibrillation--a nurse training programme in the use of automated external defibrillators. Resuscitation (1995) 1.38
Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature (2000) 1.36
CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience (2005) 1.35
Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut (1999) 1.35
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol (1998) 1.34
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. Br J Pharmacol (2010) 1.32
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol (2007) 1.32
Sensory substance P innervation of the stomach and pancreas. Demonstration of capsaicin-sensitive sensory neurons in the rat by combined immunohistochemistry and retrograde tracing. Gastroenterology (1984) 1.29
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol (2007) 1.29
Fatal cerebral hemorrhage due to autonomic dysreflexia in a tetraplegic patient: case report and review. Paraplegia (1992) 1.27
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience (2000) 1.25
Medication errors in a pediatric emergency department. Pediatr Emerg Care (1999) 1.25
Human T cell antigen expression during the early stages of fetal thymic maturation. J Immunol (1985) 1.25
Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex. J Mol Biol (2001) 1.24
Plasticity of the enteric nervous system during intestinal inflammation. Neurogastroenterol Motil (2005) 1.23
Changes in colonic motility and the electrophysiological properties of myenteric neurons persist following recovery from trinitrobenzene sulfonic acid colitis in the guinea pig. Neurogastroenterol Motil (2007) 1.23
Plasticity of enteric nerve functions in the inflamed and postinflamed gut. Neurogastroenterol Motil (2009) 1.21
The non-adrenergic, inhibitory innervation of the guinea-pig gallbladder. Pflugers Arch (1978) 1.21
Mucosal receptors in the gastric antrum and small intestine of the rat with afferent fibres in the cervical vagus. J Physiol (1978) 1.21
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur J Neurosci (2007) 1.20
Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am J Physiol (1997) 1.19
Response of single vagal afferent fibres to mechanical and chemical stimulation of the gastric and duodenal mucosa in cats. Q J Exp Physiol Cogn Med Sci (1972) 1.19
Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience (2005) 1.18
Vibronic states in single molecule electron transport. Phys Rev Lett (2004) 1.18
Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol Motil (2005) 1.17
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17
Development of one-dimensional band structure in artificial gold chains. Science (2002) 1.17
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. J Neurochem (2000) 1.17
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience (2004) 1.17
Localization of cannabinoid CB1 receptors in the human anterior eye and retina. Invest Ophthalmol Vis Sci (1999) 1.16
Enteric glia. Neurogastroenterol Motil (2004) 1.16
Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol (1994) 1.16
The in vivo and in vitro synthesis of sulphatides during development. J Neurochem (1967) 1.15
Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther (2005) 1.15
Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci (1998) 1.14
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry (2012) 1.14
The participation of the sympathetic innervation of the gastrointestinal tract in disease states. Neurogastroenterol Motil (2009) 1.13
Intratracheal instillation method for mouse lungs. Oncology (1973) 1.12
Mechanisms of reversible conformational transitions in a single molecule. Phys Rev Lett (2004) 1.12
A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience (1999) 1.12
Distribution of nitric oxide synthase in rat dorsal vagal complex and effects of microinjection of nitric oxide compounds upon gastric motor function. J Comp Neurol (1997) 1.11
Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience (2009) 1.10
CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport (2001) 1.09
An electrophysiological and anatomical study of intestinal afferent fibres in the rat. J Physiol (1988) 1.09
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol Pharmacol (1998) 1.09
Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. J Pharmacol Exp Ther (2001) 1.09
COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation. Br J Pharmacol (2011) 1.09
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut (2003) 1.08
Modulation of ion channels in rod photoreceptors by nitric oxide. Neuron (1994) 1.08
Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons. Neuroscience (2000) 1.08
Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol (2000) 1.07
Cannabinoid-receptor-independent cell signalling by N-acylethanolamines. Biochem J (2001) 1.06
Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. Proc Natl Acad Sci U S A (1999) 1.06
Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of cholesterol gallstone formation. Gastroenterology (1983) 1.06
Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther (1997) 1.06
Gastric emptying time in late pregnancy and labour. J Obstet Gynaecol Br Commonw (1970) 1.06
Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology (1997) 1.06
Temporal distribution of neuronal and inducible nitric oxide synthase and nitrotyrosine during colitis in rats. Neurogastroenterol Motil (1999) 1.06
Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med (1983) 1.06
Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors. Neurogastroenterol Motil (2009) 1.05
Correlation of morphology, electrophysiology and chemistry of neurons in the myenteric plexus of the guinea-pig distal colon. J Auton Nerv Syst (1999) 1.05